nodes	percent_of_prediction	percent_of_DWPC	metapath
Stanozolol—AR—type 2 diabetes mellitus	0.951	1	CbGaD
Stanozolol—AR—Nongenotropic Androgen signaling—SHBG—type 2 diabetes mellitus	0.0026	0.0729	CbGpPWpGaD
Stanozolol—Trilostane—HSD3B2—type 2 diabetes mellitus	0.00256	0.246	CrCbGaD
Stanozolol—AR—penis—type 2 diabetes mellitus	0.00186	0.584	CbGeAlD
Stanozolol—AR—SIDS Susceptibility Pathways—PHOX2A—type 2 diabetes mellitus	0.0013	0.0365	CbGpPWpGaD
Stanozolol—AR—Coregulation of Androgen receptor activity—ZMIZ1—type 2 diabetes mellitus	0.00115	0.0322	CbGpPWpGaD
Stanozolol—AR—Coregulation of Androgen receptor activity—NCOA6—type 2 diabetes mellitus	0.00104	0.0292	CbGpPWpGaD
Stanozolol—AR—Nuclear Receptors—HNF4A—type 2 diabetes mellitus	0.00103	0.029	CbGpPWpGaD
Stanozolol—Oxandrolone—AR—type 2 diabetes mellitus	0.000927	0.0888	CrCbGaD
Stanozolol—AR—Regulation of nuclear beta catenin signaling and target gene transcription—COX2—type 2 diabetes mellitus	0.000851	0.0239	CbGpPWpGaD
Stanozolol—AR—Androgen receptor signaling pathway—ZMIZ1—type 2 diabetes mellitus	0.000847	0.0238	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—NEUROD1—type 2 diabetes mellitus	0.000839	0.0235	CbGpPWpGaD
Stanozolol—AR—Nuclear Receptor transcription pathway—HNF4A—type 2 diabetes mellitus	0.000817	0.0229	CbGpPWpGaD
Stanozolol—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TLE4—type 2 diabetes mellitus	0.000752	0.0211	CbGpPWpGaD
Stanozolol—Drostanolone—SHBG—type 2 diabetes mellitus	0.000703	0.0674	CrCbGaD
Stanozolol—AR—FOXA1 transcription factor network—GCG—type 2 diabetes mellitus	0.000696	0.0196	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—KCNQ1—type 2 diabetes mellitus	0.000684	0.0192	CbGpPWpGaD
Stanozolol—Danazol—CCL2—type 2 diabetes mellitus	0.000667	0.064	CrCbGaD
Stanozolol—AR—SIDS Susceptibility Pathways—G6PC—type 2 diabetes mellitus	0.000635	0.0178	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—ECE1—type 2 diabetes mellitus	0.000635	0.0178	CbGpPWpGaD
Stanozolol—AR—FOXA1 transcription factor network—SOD1—type 2 diabetes mellitus	0.000621	0.0174	CbGpPWpGaD
Stanozolol—Drostanolone—AR—type 2 diabetes mellitus	0.000617	0.0591	CrCbGaD
Stanozolol—AR—Regulation of nuclear SMAD2/3 signaling—ATF3—type 2 diabetes mellitus	0.000584	0.0164	CbGpPWpGaD
Stanozolol—AR—Nuclear Receptors—NR3C1—type 2 diabetes mellitus	0.000579	0.0163	CbGpPWpGaD
Stanozolol—AR—FOXA1 transcription factor network—APOB—type 2 diabetes mellitus	0.000572	0.0161	CbGpPWpGaD
Stanozolol—AR—Regulation of nuclear SMAD2/3 signaling—HNF4A—type 2 diabetes mellitus	0.000564	0.0158	CbGpPWpGaD
Stanozolol—AR—Integrated Breast Cancer Pathway—ZMIZ1—type 2 diabetes mellitus	0.000555	0.0156	CbGpPWpGaD
Stanozolol—AR—Nuclear Receptors—PPARA—type 2 diabetes mellitus	0.000543	0.0152	CbGpPWpGaD
Stanozolol—AR—Regulation of Androgen receptor activity—SIRT1—type 2 diabetes mellitus	0.0005	0.0141	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—PLN—type 2 diabetes mellitus	0.000494	0.0139	CbGpPWpGaD
Stanozolol—AR—Nuclear Receptor transcription pathway—NR3C1—type 2 diabetes mellitus	0.000458	0.0129	CbGpPWpGaD
Stanozolol—AR—Nongenotropic Androgen signaling—PIK3R1—type 2 diabetes mellitus	0.000454	0.0128	CbGpPWpGaD
Stanozolol—AR—Nuclear Receptors—PPARG—type 2 diabetes mellitus	0.000449	0.0126	CbGpPWpGaD
Stanozolol—AR—Notch-mediated HES/HEY network—HIF1A—type 2 diabetes mellitus	0.000445	0.0125	CbGpPWpGaD
Stanozolol—AR—Regulation of Androgen receptor activity—NR3C1—type 2 diabetes mellitus	0.000444	0.0125	CbGpPWpGaD
Stanozolol—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TCF7L2—type 2 diabetes mellitus	0.000439	0.0123	CbGpPWpGaD
Stanozolol—AR—Nuclear Receptor transcription pathway—PPARA—type 2 diabetes mellitus	0.000429	0.012	CbGpPWpGaD
Stanozolol—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND2—type 2 diabetes mellitus	0.000406	0.0114	CbGpPWpGaD
Stanozolol—Fluoxymesterone—SHBG—type 2 diabetes mellitus	0.000397	0.0381	CrCbGaD
Stanozolol—AR—FOXA1 transcription factor network—INS—type 2 diabetes mellitus	0.000391	0.011	CbGpPWpGaD
Stanozolol—Danazol—SHBG—type 2 diabetes mellitus	0.00038	0.0364	CrCbGaD
Stanozolol—Testosterone Propionate—AR—type 2 diabetes mellitus	0.000376	0.036	CrCbGaD
Stanozolol—AR—Regulation of nuclear SMAD2/3 signaling—CDKN2B—type 2 diabetes mellitus	0.00036	0.0101	CbGpPWpGaD
Stanozolol—AR—Nuclear Receptor transcription pathway—PPARG—type 2 diabetes mellitus	0.000355	0.00996	CbGpPWpGaD
Stanozolol—Fluoxymesterone—AR—type 2 diabetes mellitus	0.000348	0.0334	CrCbGaD
Stanozolol—Norethindrone—SHBG—type 2 diabetes mellitus	0.000338	0.0324	CrCbGaD
Stanozolol—AR—Nongenotropic Androgen signaling—SRC—type 2 diabetes mellitus	0.000336	0.00943	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—CPT1A—type 2 diabetes mellitus	0.000334	0.00938	CbGpPWpGaD
Stanozolol—Danazol—AR—type 2 diabetes mellitus	0.000333	0.0319	CrCbGaD
Stanozolol—AR—Androgen receptor signaling pathway—SIRT1—type 2 diabetes mellitus	0.000331	0.00928	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—GCK—type 2 diabetes mellitus	0.000325	0.00914	CbGpPWpGaD
Stanozolol—Methyltestosterone—SHBG—type 2 diabetes mellitus	0.000321	0.0308	CrCbGaD
Stanozolol—AR—Regulation of nuclear SMAD2/3 signaling—NR3C1—type 2 diabetes mellitus	0.000316	0.00888	CbGpPWpGaD
Stanozolol—AR—cardiovascular system—type 2 diabetes mellitus	0.000299	0.0939	CbGeAlD
Stanozolol—AR—Coregulation of Androgen receptor activity—CASP8—type 2 diabetes mellitus	0.000296	0.00833	CbGpPWpGaD
Stanozolol—AR—kidney—type 2 diabetes mellitus	0.000293	0.0919	CbGeAlD
Stanozolol—AR—SIDS Susceptibility Pathways—SNAP25—type 2 diabetes mellitus	0.000292	0.00819	CbGpPWpGaD
Stanozolol—AR—Integrated Breast Cancer Pathway—HMGCR—type 2 diabetes mellitus	0.000291	0.00818	CbGpPWpGaD
Stanozolol—AR—cortex of kidney—type 2 diabetes mellitus	0.000285	0.0895	CbGeAlD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—HNF4A—type 2 diabetes mellitus	0.000284	0.00797	CbGpPWpGaD
Stanozolol—Methyltestosterone—AR—type 2 diabetes mellitus	0.000281	0.027	CrCbGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—IAPP—type 2 diabetes mellitus	0.000275	0.00772	CbGpPWpGaD
Stanozolol—AR—Gene Expression—IGF2BP2—type 2 diabetes mellitus	0.000265	0.00743	CbGpPWpGaD
Stanozolol—Testosterone—CYP11A1—type 2 diabetes mellitus	0.000264	0.0253	CrCbGaD
Stanozolol—AR—adipose tissue—type 2 diabetes mellitus	0.000264	0.0828	CbGeAlD
Stanozolol—AR—Coregulation of Androgen receptor activity—CDKN2A—type 2 diabetes mellitus	0.000258	0.00726	CbGpPWpGaD
Stanozolol—Fluoxymesterone—NR3C1—type 2 diabetes mellitus	0.000236	0.0227	CrCbGaD
Stanozolol—AR—SIDS Susceptibility Pathways—GJA1—type 2 diabetes mellitus	0.000233	0.00655	CbGpPWpGaD
Stanozolol—AR—Integrated Breast Cancer Pathway—TGFBR2—type 2 diabetes mellitus	0.000226	0.00634	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—TNFRSF1A—type 2 diabetes mellitus	0.000224	0.0063	CbGpPWpGaD
Stanozolol—AR—Regulation of nuclear SMAD2/3 signaling—SERPINE1—type 2 diabetes mellitus	0.000221	0.0062	CbGpPWpGaD
Stanozolol—AR—Regulation of Androgen receptor activity—SRC—type 2 diabetes mellitus	0.000219	0.00614	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—PPARGC1A—type 2 diabetes mellitus	0.000218	0.00612	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—GNB3—type 2 diabetes mellitus	0.000218	0.00612	CbGpPWpGaD
Stanozolol—AR—Integrated Breast Cancer Pathway—SIRT1—type 2 diabetes mellitus	0.000217	0.00608	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—AVP—type 2 diabetes mellitus	0.000215	0.00604	CbGpPWpGaD
Stanozolol—AR—Nongenotropic Androgen signaling—AKT1—type 2 diabetes mellitus	0.000209	0.00586	CbGpPWpGaD
Stanozolol—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—type 2 diabetes mellitus	0.000208	0.00584	CbGpPWpGaD
Stanozolol—AR—Generic Transcription Pathway—NCOA6—type 2 diabetes mellitus	0.000207	0.00581	CbGpPWpGaD
Stanozolol—Progesterone—SHBG—type 2 diabetes mellitus	0.000197	0.0189	CrCbGaD
Stanozolol—AR—Androgen receptor signaling pathway—PIK3R1—type 2 diabetes mellitus	0.000195	0.00549	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—NR3C1—type 2 diabetes mellitus	0.000187	0.00526	CbGpPWpGaD
Stanozolol—Testosterone—SHBG—type 2 diabetes mellitus	0.000186	0.0178	CrCbGaD
Stanozolol—AR—liver—type 2 diabetes mellitus	0.000185	0.0581	CbGeAlD
Stanozolol—AR—Androgen receptor signaling pathway—RELA—type 2 diabetes mellitus	0.000184	0.00516	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—CDKN2B—type 2 diabetes mellitus	0.000181	0.00509	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—SIRT1—type 2 diabetes mellitus	0.000179	0.00504	CbGpPWpGaD
Stanozolol—AR—Integrated Breast Cancer Pathway—MMP1—type 2 diabetes mellitus	0.000177	0.00496	CbGpPWpGaD
Stanozolol—Progesterone—AR—type 2 diabetes mellitus	0.000173	0.0165	CrCbGaD
Stanozolol—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—type 2 diabetes mellitus	0.000171	0.00479	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—HIF1A—type 2 diabetes mellitus	0.00017	0.00479	CbGpPWpGaD
Stanozolol—Testosterone—AR—type 2 diabetes mellitus	0.000163	0.0156	CrCbGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—FAS—type 2 diabetes mellitus	0.000154	0.00433	CbGpPWpGaD
Stanozolol—AR—Integrated Breast Cancer Pathway—IRS1—type 2 diabetes mellitus	0.000152	0.00428	CbGpPWpGaD
Stanozolol—AR—Androgen receptor signaling pathway—SRC—type 2 diabetes mellitus	0.000144	0.00406	CbGpPWpGaD
Stanozolol—AR—Integrated Breast Cancer Pathway—CASP8—type 2 diabetes mellitus	0.000144	0.00403	CbGpPWpGaD
Stanozolol—AR—Generic Transcription Pathway—HNF4A—type 2 diabetes mellitus	0.000141	0.00396	CbGpPWpGaD
Stanozolol—Danazol—CYP3A4—type 2 diabetes mellitus	0.000131	0.0125	CrCbGaD
Stanozolol—AR—Androgen receptor signaling pathway—EGFR—type 2 diabetes mellitus	0.000127	0.00356	CbGpPWpGaD
Stanozolol—AR—Integrated Breast Cancer Pathway—BCL2—type 2 diabetes mellitus	0.000123	0.00346	CbGpPWpGaD
Stanozolol—AR—Coregulation of Androgen receptor activity—AKT1—type 2 diabetes mellitus	0.000121	0.00341	CbGpPWpGaD
Stanozolol—AR—Generic Transcription Pathway—CTGF—type 2 diabetes mellitus	0.000121	0.0034	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—CASP8—type 2 diabetes mellitus	0.000119	0.00334	CbGpPWpGaD
Stanozolol—Progesterone—NR3C1—type 2 diabetes mellitus	0.000117	0.0112	CrCbGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—IGF1—type 2 diabetes mellitus	0.000117	0.00328	CbGpPWpGaD
Stanozolol—Norethindrone—CYP3A4—type 2 diabetes mellitus	0.000116	0.0112	CrCbGaD
Stanozolol—Methyltestosterone—CYP3A4—type 2 diabetes mellitus	0.000111	0.0106	CrCbGaD
Stanozolol—AR—Integrated Breast Cancer Pathway—CASP3—type 2 diabetes mellitus	0.000109	0.00305	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—CASP3—type 2 diabetes mellitus	0.000106	0.00297	CbGpPWpGaD
Stanozolol—AR—Generic Transcription Pathway—NOTCH2—type 2 diabetes mellitus	0.000105	0.00294	CbGpPWpGaD
Stanozolol—Progesterone—CYP1A2—type 2 diabetes mellitus	0.000103	0.00983	CrCbGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—BCL2—type 2 diabetes mellitus	0.000102	0.00287	CbGpPWpGaD
Stanozolol—Norethindrone—ALB—type 2 diabetes mellitus	0.000102	0.00974	CrCbGaD
Stanozolol—AR—Integrated Breast Cancer Pathway—NFKB1—type 2 diabetes mellitus	0.000102	0.00285	CbGpPWpGaD
Stanozolol—AR—Gene Expression—NCOA6—type 2 diabetes mellitus	9.96e-05	0.0028	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—NFKB1—type 2 diabetes mellitus	9.9e-05	0.00278	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—PTGS2—type 2 diabetes mellitus	9.7e-05	0.00272	CbGpPWpGaD
Stanozolol—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—type 2 diabetes mellitus	9.68e-05	0.00272	CbGpPWpGaD
Stanozolol—Methyltestosterone—ALB—type 2 diabetes mellitus	9.65e-05	0.00925	CrCbGaD
Stanozolol—AR—Integrated Breast Cancer Pathway—VEGFA—type 2 diabetes mellitus	9.22e-05	0.00259	CbGpPWpGaD
Stanozolol—AR—Generic Transcription Pathway—CDKN2B—type 2 diabetes mellitus	9.01e-05	0.00253	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—CASP3—type 2 diabetes mellitus	9e-05	0.00253	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—VEGFA—type 2 diabetes mellitus	8.98e-05	0.00252	CbGpPWpGaD
Stanozolol—AR—Androgen receptor signaling pathway—AKT1—type 2 diabetes mellitus	8.98e-05	0.00252	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—NFKB1—type 2 diabetes mellitus	8.42e-05	0.00236	CbGpPWpGaD
Stanozolol—AR—Integrated Breast Cancer Pathway—EGFR—type 2 diabetes mellitus	8.3e-05	0.00233	CbGpPWpGaD
Stanozolol—AR—Generic Transcription Pathway—NR3C1—type 2 diabetes mellitus	7.91e-05	0.00222	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	7.84e-05	0.0022	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—TNF—type 2 diabetes mellitus	7.7e-05	0.00216	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	7.64e-05	0.00215	CbGpPWpGaD
Stanozolol—AR—Generic Transcription Pathway—PPARA—type 2 diabetes mellitus	7.41e-05	0.00208	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	7.01e-05	0.00197	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	6.87e-05	0.00193	CbGpPWpGaD
Stanozolol—AR—Gene Expression—HNF4A—type 2 diabetes mellitus	6.79e-05	0.00191	CbGpPWpGaD
Stanozolol—Progesterone—CYP3A4—type 2 diabetes mellitus	6.79e-05	0.00651	CrCbGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	6.55e-05	0.00184	CbGpPWpGaD
Stanozolol—Testosterone—CYP3A4—type 2 diabetes mellitus	6.42e-05	0.00615	CrCbGaD
Stanozolol—AR—SIDS Susceptibility Pathways—IL6—type 2 diabetes mellitus	6.21e-05	0.00174	CbGpPWpGaD
Stanozolol—AR—Generic Transcription Pathway—PPARG—type 2 diabetes mellitus	6.12e-05	0.00172	CbGpPWpGaD
Stanozolol—AR—Gene Expression—PSMD6—type 2 diabetes mellitus	5.94e-05	0.00167	CbGpPWpGaD
Stanozolol—AR—Gene Expression—DNMT1—type 2 diabetes mellitus	5.94e-05	0.00167	CbGpPWpGaD
Stanozolol—AR—Integrated Breast Cancer Pathway—AKT1—type 2 diabetes mellitus	5.88e-05	0.00165	CbGpPWpGaD
Stanozolol—AR—Gene Expression—CTGF—type 2 diabetes mellitus	5.83e-05	0.00164	CbGpPWpGaD
Stanozolol—Testosterone—ALB—type 2 diabetes mellitus	5.6e-05	0.00536	CrCbGaD
Stanozolol—AR—Generic Transcription Pathway—SERPINE1—type 2 diabetes mellitus	5.52e-05	0.00155	CbGpPWpGaD
Stanozolol—AR—Gene Expression—NOTCH2—type 2 diabetes mellitus	5.05e-05	0.00142	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	4.87e-05	0.00137	CbGpPWpGaD
Stanozolol—AR—Gene Expression—CDKN2B—type 2 diabetes mellitus	4.34e-05	0.00122	CbGpPWpGaD
Stanozolol—AR—Gene Expression—SIRT1—type 2 diabetes mellitus	4.29e-05	0.00121	CbGpPWpGaD
Stanozolol—AR—Gene Expression—NR3C1—type 2 diabetes mellitus	3.81e-05	0.00107	CbGpPWpGaD
Stanozolol—AR—Gene Expression—PPP2CA—type 2 diabetes mellitus	3.79e-05	0.00106	CbGpPWpGaD
Stanozolol—AR—Gene Expression—PPARA—type 2 diabetes mellitus	3.57e-05	0.001	CbGpPWpGaD
Stanozolol—AR—Gene Expression—PPARG—type 2 diabetes mellitus	2.95e-05	0.000828	CbGpPWpGaD
Stanozolol—AR—Gene Expression—SERPINE1—type 2 diabetes mellitus	2.66e-05	0.000746	CbGpPWpGaD
Stanozolol—AR—Gene Expression—AKT1—type 2 diabetes mellitus	1.17e-05	0.000327	CbGpPWpGaD
